Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras

Frederick Goldman, Raymond Hohl, John Crabtree, Kriste Lewis-Tibesar, Gary Koretzky

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Lovastatin, a cholesterol-lowering drug, has antiproliferative properties that may be related to its inhibition of protein isoprenylation. We examined the effects of lovastatin on signal transduction via the T-cell antigen receptor (TCR). Lovastatin inhibited both proximal and distal TCR- mediated signaling events in a time- and concentration-dependent manner in the human Jurkat T-cell line. Upregulation of CD69 surface expression after TCR stimulation was blocked by lovastatin, although no inhibition of phorbol ester-induced CD69 expression was noted. Proximal TCR-mediated signaling events, including intracellular calcium mobilization, inositol phosphate production, and tyrosine phosphorylation of phospholipase Cγ1, were similarly inhibited by lovastatin, although global protein tyrosine kinase activity remained intact. In a Jurkat variant transfected with the human type-1 muscarinic receptor, lovastatin also inhibited TCR-mediated calcium mobilization and inositol phosphate production but failed to affect muscarinic receptor-induced responses. Lovastatin, at similar doses, also disrupted posttranslational processing of ras and inhibited ras-dependent signals, including phosphorylation and activation of mitogen-associated protein kinase after TCR stimulation. These findings suggest that the antiproliferative properties of lovastatin may be independent of ras and could result from uncoupling protein tyrosine kinases from distinct signal transduction pathways.

Original languageEnglish (US)
Pages (from-to)4611-4619
Number of pages9
JournalBlood
Volume88
Issue number12
StatePublished - Dec 15 1996

Fingerprint

Lovastatin
T-Cell Antigen Receptor
Signal transduction
Phosphorylation
Inositol Phosphates
Muscarinic Receptors
Protein-Tyrosine Kinases
Signal Transduction
Protein Prenylation
Calcium
Jurkat Cells
T-cells
Phorbol Esters
Mitogens
Protein Kinases
Tyrosine
Up-Regulation
Chemical activation
Cholesterol
T-Lymphocytes

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Goldman, F., Hohl, R., Crabtree, J., Lewis-Tibesar, K., & Koretzky, G. (1996). Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. Blood, 88(12), 4611-4619.
Goldman, Frederick ; Hohl, Raymond ; Crabtree, John ; Lewis-Tibesar, Kriste ; Koretzky, Gary. / Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. In: Blood. 1996 ; Vol. 88, No. 12. pp. 4611-4619.
@article{4bfe4b6885394137b8f9fbfd6ac0c9dd,
title = "Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras",
abstract = "Lovastatin, a cholesterol-lowering drug, has antiproliferative properties that may be related to its inhibition of protein isoprenylation. We examined the effects of lovastatin on signal transduction via the T-cell antigen receptor (TCR). Lovastatin inhibited both proximal and distal TCR- mediated signaling events in a time- and concentration-dependent manner in the human Jurkat T-cell line. Upregulation of CD69 surface expression after TCR stimulation was blocked by lovastatin, although no inhibition of phorbol ester-induced CD69 expression was noted. Proximal TCR-mediated signaling events, including intracellular calcium mobilization, inositol phosphate production, and tyrosine phosphorylation of phospholipase Cγ1, were similarly inhibited by lovastatin, although global protein tyrosine kinase activity remained intact. In a Jurkat variant transfected with the human type-1 muscarinic receptor, lovastatin also inhibited TCR-mediated calcium mobilization and inositol phosphate production but failed to affect muscarinic receptor-induced responses. Lovastatin, at similar doses, also disrupted posttranslational processing of ras and inhibited ras-dependent signals, including phosphorylation and activation of mitogen-associated protein kinase after TCR stimulation. These findings suggest that the antiproliferative properties of lovastatin may be independent of ras and could result from uncoupling protein tyrosine kinases from distinct signal transduction pathways.",
author = "Frederick Goldman and Raymond Hohl and John Crabtree and Kriste Lewis-Tibesar and Gary Koretzky",
year = "1996",
month = "12",
day = "15",
language = "English (US)",
volume = "88",
pages = "4611--4619",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

Goldman, F, Hohl, R, Crabtree, J, Lewis-Tibesar, K & Koretzky, G 1996, 'Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras', Blood, vol. 88, no. 12, pp. 4611-4619.

Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. / Goldman, Frederick; Hohl, Raymond; Crabtree, John; Lewis-Tibesar, Kriste; Koretzky, Gary.

In: Blood, Vol. 88, No. 12, 15.12.1996, p. 4611-4619.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras

AU - Goldman, Frederick

AU - Hohl, Raymond

AU - Crabtree, John

AU - Lewis-Tibesar, Kriste

AU - Koretzky, Gary

PY - 1996/12/15

Y1 - 1996/12/15

N2 - Lovastatin, a cholesterol-lowering drug, has antiproliferative properties that may be related to its inhibition of protein isoprenylation. We examined the effects of lovastatin on signal transduction via the T-cell antigen receptor (TCR). Lovastatin inhibited both proximal and distal TCR- mediated signaling events in a time- and concentration-dependent manner in the human Jurkat T-cell line. Upregulation of CD69 surface expression after TCR stimulation was blocked by lovastatin, although no inhibition of phorbol ester-induced CD69 expression was noted. Proximal TCR-mediated signaling events, including intracellular calcium mobilization, inositol phosphate production, and tyrosine phosphorylation of phospholipase Cγ1, were similarly inhibited by lovastatin, although global protein tyrosine kinase activity remained intact. In a Jurkat variant transfected with the human type-1 muscarinic receptor, lovastatin also inhibited TCR-mediated calcium mobilization and inositol phosphate production but failed to affect muscarinic receptor-induced responses. Lovastatin, at similar doses, also disrupted posttranslational processing of ras and inhibited ras-dependent signals, including phosphorylation and activation of mitogen-associated protein kinase after TCR stimulation. These findings suggest that the antiproliferative properties of lovastatin may be independent of ras and could result from uncoupling protein tyrosine kinases from distinct signal transduction pathways.

AB - Lovastatin, a cholesterol-lowering drug, has antiproliferative properties that may be related to its inhibition of protein isoprenylation. We examined the effects of lovastatin on signal transduction via the T-cell antigen receptor (TCR). Lovastatin inhibited both proximal and distal TCR- mediated signaling events in a time- and concentration-dependent manner in the human Jurkat T-cell line. Upregulation of CD69 surface expression after TCR stimulation was blocked by lovastatin, although no inhibition of phorbol ester-induced CD69 expression was noted. Proximal TCR-mediated signaling events, including intracellular calcium mobilization, inositol phosphate production, and tyrosine phosphorylation of phospholipase Cγ1, were similarly inhibited by lovastatin, although global protein tyrosine kinase activity remained intact. In a Jurkat variant transfected with the human type-1 muscarinic receptor, lovastatin also inhibited TCR-mediated calcium mobilization and inositol phosphate production but failed to affect muscarinic receptor-induced responses. Lovastatin, at similar doses, also disrupted posttranslational processing of ras and inhibited ras-dependent signals, including phosphorylation and activation of mitogen-associated protein kinase after TCR stimulation. These findings suggest that the antiproliferative properties of lovastatin may be independent of ras and could result from uncoupling protein tyrosine kinases from distinct signal transduction pathways.

UR - http://www.scopus.com/inward/record.url?scp=0029858008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029858008&partnerID=8YFLogxK

M3 - Article

C2 - 8977253

AN - SCOPUS:0029858008

VL - 88

SP - 4611

EP - 4619

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -

Goldman F, Hohl R, Crabtree J, Lewis-Tibesar K, Koretzky G. Lovastatin inhibits T-cell antigen receptor signaling independent of its effects on ras. Blood. 1996 Dec 15;88(12):4611-4619.